Elizabeth Reed files Form 144 to sell 2,076 shares

Elizabeth Reed filed a Form 144 reporting an intended sale of 2,076 shares of Common Stock (listed as Performance Shares) with an execution date of 05/04/2026.

Rhea-AI Filing Summary

Elizabeth Reed filed a Form 144 reporting an intended sale of 2,076 shares of Common Stock (listed as Performance Shares) with an execution date of 05/04/2026.

The filing lists prior sales by the same holder during the past three months, including a 20,000-share sale on 05/04/2026 and a 37,500-share sale on 04/14/2026, with corresponding proceeds shown in the excerpt.

Insights

Securities Counsel

Routine Rule 144 notice for an issuer-affiliated sale; no new corporate action disclosed.

The filing is a Form 144 notice that lists an intended sale of 2,076 shares of Common Stock (identified as Performance Shares) with an intended sale date of 05/04/2026. The entry labels the transaction as ISSUER.

Several prior sales by the same reporting person are listed for the recent three-month period. The excerpt shows sale quantities and gross proceeds; cash-flow treatment and any placement method are not stated in the provided text.

Key Figures

Registered/offered shares: 2,076 shares Sale example 1: 20,000 shares Sale example 2: 37,500 shares +1 more

4 metrics

Registered/offered shares 2,076 shares Securities to be sold listed with date 05/04/2026

Sale example 1 20,000 shares Sale on 05/04/2026 with proceeds $900,000 shown

Sale example 2 37,500 shares Sale on 04/14/2026 with proceeds $1,540,125 shown

Sale example 3 6,785 shares Sale on 04/15/2026 with proceeds $283,823.34 shown

Key Terms

Form 144, Performance Shares, ISSUER

3 terms

Form 144 regulatory

"144: Securities To Be Sold Common 05/04/2026 Performance Shares"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Performance Shares financial

"Securities To Be Sold Common 05/04/2026 Performance Shares"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

ISSUER regulatory

"Common | 05/04/2026 | Performance Shares | ISSUER"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Elizabeth Reed's Form 144 for TVTX report?

It reports an intended sale of 2,076 shares of Common Stock (Performance Shares) with an execution date of 05/04/2026. The filing also lists multiple recent sales by the same holder showing quantities and gross proceeds.

How many shares are listed to be sold on the Form 144 for TVTX?

The filing lists 2,076 shares of Common Stock (Performance Shares) as the securities to be sold with an intended sale date of 05/04/2026. The excerpt uses the label ISSUER for the transaction entry.

Does the Form 144 show recent sales by the same holder for TVTX?

Yes. The excerpt lists multiple past three-month sales by Elizabeth Reed, including a 20,000-share sale on 05/04/2026 and a 37,500-share sale on 04/14/2026, with gross proceeds shown for each transaction.

Does the Form 144 specify proceeds recipient or sale method for TVTX?

The excerpt shows gross proceeds for specific past sales but does not state who receives proceeds or the distribution method for the 2,076-share offering. The filing labels the security entry as ISSUER without further cash-flow detail.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/06/2026 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001283303
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	TRAVERE THERAPEUTICS, INC.
SEC File Number	001-36257
Address of Issuer	3611 Valley Centre Drive Suite 300 San Diego CALIFORNIA 92130
Phone	888-969-7879
Name of Person for Whose Account the Securities are To Be Sold	ELIZABETH REED
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	2076	91240.20	92992905	05/06/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	05/04/2026	Performance Shares	ISSUER			2076	05/04/2026	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	05/05/2026	2174	101417.10
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	05/04/2026	20000	900000.00
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/15/2026	6785	283823.34
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/14/2026	37500	1540125.00
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/14/2026	7215	302516.29
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	04/01/2026	10000	300000.00
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	03/16/2026	10000	280861.00
ELIZABETH REED 3611 Valley Centre Drive Suite 300 San Diego CA 92130	Common	02/17/2026	10000	278317.00

144: Remarks and Signature

Remarks
Date of Notice	05/06/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/16/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Elizabeth E. Reed
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)